Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Drug Approval | 1 | 2020 | 1325 | 0.43 | Why? |
| Immunization, Passive | 12 | 2021 | 10067 | 0.25 | Why? |
| Heparin | 2 | 2021 | 2600 | 0.18 | Why? |
| Non-Randomized Controlled Trials as Topic | 3 | 2021 | 220 | 0.15 | Why? |
| Immunoglobulins | 1 | 2020 | 811 | 0.14 | Why? |
| Erythrocyte Transfusion | 1 | 2017 | 386 | 0.13 | Why? |
| Receptors, Interleukin-6 | 1 | 2021 | 1383 | 0.12 | Why? |
| Randomized Controlled Trials as Topic | 8 | 2021 | 10649 | 0.11 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.11 | Why? |
| Coronavirus Infections | 9 | 2021 | 253789 | 0.11 | Why? |
| Hydrocortisone | 1 | 2020 | 1790 | 0.10 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.10 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.10 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.09 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.09 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.09 | Why? |
| Early Termination of Clinical Trials | 2 | 2020 | 1256 | 0.08 | Why? |
| Respiration, Artificial | 6 | 2021 | 22116 | 0.08 | Why? |
| Cause of Death | 4 | 2021 | 4823 | 0.08 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.08 | Why? |
| Treatment Outcome | 9 | 2021 | 51732 | 0.07 | Why? |
| Bias | 2 | 2021 | 1109 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Critical Illness | 6 | 2021 | 17281 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.06 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.05 | Why? |
| Selection Bias | 1 | 2020 | 201 | 0.05 | Why? |
| Humans | 21 | 2021 | 930598 | 0.05 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Hemorrhage | 2 | 2021 | 3013 | 0.05 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Plasmapheresis | 1 | 2020 | 437 | 0.04 | Why? |
| Ventilator Weaning | 1 | 2021 | 536 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.04 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.03 | Why? |
| Research Design | 2 | 2020 | 5830 | 0.03 | Why? |
| Donor Selection | 1 | 2020 | 804 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Shock | 1 | 2020 | 1868 | 0.03 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.03 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Data Collection | 1 | 2020 | 1769 | 0.03 | Why? |
| Tissue Donors | 1 | 2020 | 1679 | 0.03 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Research | 1 | 2020 | 2115 | 0.02 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.02 | Why? |
| Aged | 5 | 2021 | 215776 | 0.02 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.02 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Male | 6 | 2021 | 367725 | 0.02 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Female | 5 | 2021 | 380317 | 0.02 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
Estcourt's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(80)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1362)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_